Showing results (231-240 of 279) with videos related to
Sort By:
Pageof 28
International Journal of Cardiology|May 28, 2003
Does a prolonged QT peak identify left ventricular hypertrophy in hypertension?K Y K Wong, P O Lim, S Y S Wong, et al.Clinical Science (London, England : 1979)|April 1, 1986
Human calcitonin gene related peptide: a potent endogenous vasodilator in manA D Struthers, M J Brown, D W Macdonald, et al.European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthmaB J Lipworth, R A Clark, D P Dhillon, et al.Pharmacogenetics|March 27, 2001
Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on raceC M Stein, C C Lang, H G Xie, et al.Clinical Pharmacology and Therapeutics|June 1, 1996
Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjectsC C Lang, C M Stein, H B He, et al.Heart (British Cardiac Society)|September 16, 2005
Spectrum of cardiac abnormalities associated with long QT in stroke survivorsK Y K Wong, S McSwiggan, N S J Kennedy, et al.Lancet (London, England)|November 20, 1997
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careM R Cowie, A D Struthers, D A Wood, et al.Clinical Pharmacology and Therapeutics|November 14, 1997
Vasodilation in black Americans: attenuated nitric oxide-mediated responsesC M Stein, C C Lang, R Nelson, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 1998
Prostaglandin production contributes to exercise-induced vasodilation in heart failureC C Lang, D B Chomsky, J Butler, et al.Journal of the Royal Society of Medicine|August 1, 1992
General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regionsJ Keys, P H Beardon, C Lau, et al.Pageof 28